AGF Investments Inc’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-3,479
Closed -$961K 598
2021
Q4
$961K Buy
3,479
+1,137
+49% +$288K 0.01% 432
2021
Q3
$541K Buy
2,342
+1,372
+141% +$339K ﹤0.01% 480
2021
Q2
$223K Sell
970
-1,050
-52% -$211K ﹤0.01% 536
2021
Q1
$377K Buy
2,020
+636
+46% +$124K ﹤0.01% 522
2020
Q4
$234K Sell
1,384
-1,099
-44% -$164K ﹤0.01% 553
2020
Q3
$368K Buy
2,483
+490
+25% +$75.8K ﹤0.01% 490
2020
Q2
$327K Sell
1,993
-229
-10% -$35.2K ﹤0.01% 487
2020
Q1
$308K Buy
+2,222
New +$305K ﹤0.01% 451
2017
Q2
Sell
-230
Closed -$19K 430
2017
Q1
$19K Buy
+230
New +$18.4K ﹤0.01% 435
2014
Q2
Sell
-5,600
Closed -$330K 410
2014
Q1
$330K Sell
5,600
-300
-5% -$16.7K ﹤0.01% 375
2013
Q4
$301K Buy
+5,900
New +$295K ﹤0.01% 384

Other funds holding LLY

AGF Investments Inc's LLY Position: Q1 2022 in Review

AGF Investments Inc sold out of Eli Lilly (LLY) in Q1 2022, closing a stake of 3,479 shares — an estimated $961K sold.

AGF Investments Inc first reported a position in LLY in Q4 2013 and held it in 11 quarters. The position peaked at $961K in Q4 2021. 2,345 funds tracked by Wall St. Rank hold LLY as of Q1 2022.

  • AGF Investments Inc reported no remaining Eli Lilly position as of Q1 2022 after selling out during the quarter.
  • AGF Investments Inc sold 3,479 Eli Lilly shares in Q1 2022, an estimated $961K.
  • AGF Investments Inc first reported a position in Eli Lilly in Q4 2013 and held it in 11 quarters.
  • AGF Investments Inc's Eli Lilly position peaked at $961K in Q4 2021.
  • 2,345 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2022.

Based on AGF Investments Inc's 13F filing for Q1 2022, filed 10 May 2022.